Maarten M.J. Wijnenga

1.7k citations

21 papers · 818 indexed · h-index 11

Genetics top 1%
- Glioma Diagnosis and Treatment 19
Radiology, Nuclear Medicine and Imaging top 5%
- Radiomics and Machine Learning in Medical Imaging 10
- Medical Imaging Techniques and Applications 2
Structural Biology top 10%
Neurology top 10%
- Neuroblastoma Research and Treatments 2
Cancer Research
- MicroRNA in disease regulation 3
Epidemiology
- Meningioma and schwannoma management 4
Pulmonary and Respiratory Medicine
- Brain Metastases and Treatment 3
- Ferroptosis and cancer prognosis 2

Co-authors: Martin J. van den Bent Hendrikus J. Dubbink Marion Smits Pim J. French Arnaud J.P.E. Vincent Johan M. Kros Peggy N. Atmodimedjo Renske Gahrmann
Cited by: Genetics Radiology, Nuclear Medicine and Imaging Structural Biology
Journals: Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)Clinical Cancer Research (2 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

Maarten M.J. Wijnenga

20 papers receiving 812 citations

Peers

Countries citing papers authored by Maarten M.J. Wijnenga

Since Specialization

Citations

This map shows the geographic impact of Maarten M.J. Wijnenga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maarten M.J. Wijnenga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maarten M.J. Wijnenga more than expected).

Fields of papers citing papers by Maarten M.J. Wijnenga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maarten M.J. Wijnenga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maarten M.J. Wijnenga. The network helps show where Maarten M.J. Wijnenga may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Maarten M.J. Wijnenga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maarten M.J. Wijnenga Line = papers co-authored together Maarten M.J. Wijnenga links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The use of minor response, volumetric assessment, and growth rate kinetics as endpoints in grade 1-3 glioma clinical trials: a RANO perspective Neuro-Oncology ·Martin J. van den Bent,Timothy F. Cloughesy,Benjamin M. Ellingson,Joshua E. Allen,Samuel C. Blackman,Mark W. Kieran,J. C. Tonn,Philipp Karschnia,Maarten M.J. Wijnenga,Johan Pallud,Robert J. Young,Raymond Y. Huang,Ingo K. Mellinghoff,John de Groot,Anouk van der Hoorn,Gilbert Youssef,Shawn L. Hervey‐Jumper,Michael A. Vogelbaum,Susan M. Chang,Patrick Y. Wen	2025	1
2	A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: A report by the RANO resect group. Journal of Clinical Oncology ·Philipp Karschnia,Jacob S. Young,Maarten M.J. Wijnenga,Arthur Wagner,Oliver Schnell,Levin Häni,Yoshua Esquenazi,Einar Osland Vik-Mo,Roberta Rudà,Michael A. Vogelbaum,Shawn L. Hervey‐Jumper,Jürgen Beck,Jörg Dietrich,Stefan Grau,Yae Won Park,Gilbert Youssef,Asgeir Store Jakola,Lorenzo Bello,Mitchel S. Berger,J. C. Tonn,(unknown)	2025	0
3	Incorporating Targeted Therapy Into Neuro-Oncology Practice American Society of Clinical Oncology Educational Book ·Marjolein Geurts,Juan Bautista Blaquier,Maarten M.J. Wijnenga,David Kamson,Macarena I. de la Fuente	2025	1
4	Differences in the Prognostic Role of Age, Extent of Resection, and Tumor Grade between Astrocytoma IDHmt and Oligodendroglioma: A Single-Center Cohort Study Clinical Cancer Research ·Thijs van der Vaart,Maarten M.J. Wijnenga,Karin A. van Garderen,Hendrikus J. Dubbink,Pim J. French,Marion Smits,Clemens M.F. Dirven,Johan M. Kros,Arnaud J.P.E. Vincent,Martin J. van den Bent	2024	4
5	Education and training in neurology: developments and future challenges European Journal of Neurology ·Matthijs van der Meulen,Maarten M.J. Wijnenga	2024	3
6	Glioblastoma lacking necrosis or vascular proliferations: Different clinical presentation but similar outcome, regardless of histology or isolated TERT promoter mutation Neuro-Oncology Advances ·Maarten M.J. Wijnenga,Sybren L. N. Maas,Vera van Dis,C. Mircea S. Tesileanu,Johan M. Kros,Linda Dirven,Hans Marten Hazelbag,Hendrikus J. Dubbink,Arnaud J.P.E. Vincent,Pim J. French,Martin J. van den Bent	2023	4
7	Evaluating the Predictive Value of Glioma Growth Models for Low-Grade Glioma After Tumor Resection IEEE Transactions on Medical Imaging ·Karin A. van Garderen,Sebastian R. van der Voort,Maarten M.J. Wijnenga,Fatih Incekara,Ahmad Alafandi,Georgios Kapsas,Renske Gahrmann,Joost W. Schouten,Hendrikus J. Dubbink,Arnaud J.P.E. Vincent,Martin J. van den Bent,Pim J. French,Marion Smits,Stefan Klein	2023	4
8	Combined molecular subtyping, grading, and segmentation of glioma using multi-task deep learning Neuro-Oncology ·Sebastian R. van der Voort,Fatih Incekara,Maarten M.J. Wijnenga,Georgios Kapsas,Renske Gahrmann,Joost W. Schouten,Rishi Nandoe Tewarie,Geert J. Lycklama,Philip C. De Witt Hamer,Roelant S. Eijgelaar,Pim J. French,Hendrikus J. Dubbink,Arnaud J.P.E. Vincent,Wiro J. Niessen,Martin J. van den Bent,Marion Smits,Stefan Klein	2022	100
9	OS07.8.A Prognosis in IDH-mutant glioma: the role of extent-of-resection, age and tumor grade Neuro-Oncology ·Thijs van der Vaart,Maarten M.J. Wijnenga,Karin A. van Garderen,H J Dubbink,Pim J. French,Marion Smits,Clemens M.F. Dirven,J. M. Kros,Agustinus Vincent,Martin J. van den Bent	2022	2
10	IDH1/2wildtype gliomas grade 2 and 3 with molecular glioblastoma-like profile have a distinct course of epilepsy compared toIDH1/2wildtype glioblastomas Neuro-Oncology ·Mark P. van Opijnen,C. Mircea S. Tesileanu,Linda Dirven,Pim B. van der Meer,Maarten M.J. Wijnenga,Arnaud J.P.E. Vincent,Marike L. D. Broekman,Hendrikus J. Dubbink,Johan M. Kros,Sjoerd G. van Duinen,Marion Smits,Pim J. French,Martin J. van den Bent,Martin Taphoorn,Johan A F Koekkoek	2022	16
11	The Erasmus Glioma Database (EGD): Structural MRI scans, WHO 2016 subtypes, and segmentations of 774 patients with glioma SHILAP Revista de lepidopterología ·Sebastian R. van der Voort,Fatih Incekara,Maarten M.J. Wijnenga,Georgios Kapsas,Renske Gahrmann,Joost W. Schouten,Hendrikus J. Dubbink,Arnaud J.P.E. Vincent,Martin J. van den Bent,Pim J. French,Stefan Klein,Marion Smits	2021	24
12	Predicting the 1p/19q Codeletion Status of Presumed Low-Grade Glioma with an Externally Validated Machine Learning Algorithm Clinical Cancer Research ·Sebastian R. van der Voort,Fatih Incekara,Maarten M.J. Wijnenga,Georgios Kapas,Mayke Gardeniers,Joost W. Schouten,Martijn P. A. Starmans,Rishi Nandoe Tewarie,Geert J. Lycklama,Pim J. French,Hendrikus J. Dubbink,Martin J. van den Bent,Arnaud J.P.E. Vincent,Wiro J. Niessen,Stefan Klein,Marion Smits	2019	69
13	Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria Neuro-Oncology ·C. Mircea S. Tesileanu,Linda Dirven,Maarten M.J. Wijnenga,Johan A F Koekkoek,Arnaud J.P.E. Vincent,Hendrikus J. Dubbink,Peggy N. Atmodimedjo,Johan M. Kros,Sjoerd G. van Duinen,Marion Smits,Martin Taphoorn,Pim J. French,Martin J. van den Bent	2019	146
14	Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma Journal of Neuro-Oncology ·Maarten M.J. Wijnenga,Pim J. French,Hendrikus J. Dubbink,Winand N.M. Dinjens,Peggy N. Atmodimedjo,Johan M. Kros,Ruth Fleischeuer,Clemens M.F. Dirven,Arnaud J.P.E. Vincent,Martin J. van den Bent	2018	21
15	The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study Neuro-Oncology ·Martinus P G Broen,Marion Smits,Maarten M.J. Wijnenga,Hendrikus J. Dubbink,Monique Anten,Olaf Schijns,Jan Beckervordersandforth,Alida A. Postma,Martin J. van den Bent	2018	135
16	The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis Neuro-Oncology ·Maarten M.J. Wijnenga,Pim J. French,Hendrikus J. Dubbink,Winand N.M. Dinjens,Peggy N. Atmodimedjo,Johan M. Kros,Marion Smits,Renske Gahrmann,Geert‐Jan Rutten,Jeroen B. Verheul,Ruth Fleischeuer,Clemens M.F. Dirven,Arnaud J.P.E. Vincent,Martin J. van den Bent	2017	217
17	Does early resection of presumed low-grade glioma improve survival? A clinical perspective Journal of Neuro-Oncology ·Maarten M.J. Wijnenga,Tariq Mattni,Pim J. French,Geert-Jan Rutten,Sieger Leenstra,Fred Kloet,Martin Taphoorn,Martin J. van den Bent,Clemens M.F. Dirven,Marie‐Lise C. van Veelen,Arnaud J.P.E. Vincent	2017	30
18	SURG-05. THE IMPACT OF SURGERY IN MOLECULARLY DEFINED LOW-GRADE GLIOMA: AN INTEGRATED CLINICAL, RADIOLOGICAL AND MOLECULAR ANALYSIS Neuro-Oncology ·Maarten M.J. Wijnenga,Pim J. French,Hendrikus J. Dubbink,Winand N.M. Dinjens,Peggy N. Atmodimedjo,Johan M. Kros,Marion Smits,Renske Gahrmann,Geert‐Jan Rutten,Jeroen B. Verheul,Ruth Fleischeuer,Clemens M.F. Dirven,Arnaud J.P.E. Vincent,Martin J. van den Bent	2017	1
19	OS5.6 Initial treatment strategy for presumed low-grade glioma: a preoperative perspective Neuro-Oncology ·Maarten M.J. Wijnenga,Tariq Mattni,Pim J. French,Geert-Jan Rutten,Sieger Leenstra,Fred Kloet,M. J. B. Taphoorn,Martin J. van den Bent,Marie‐Lise C. van Veelen,Arnaud J.P.E. Vincent	2016	1
20	PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients Acta Neuropathologica Communications ·Kaspar Draaisma,Maarten M.J. Wijnenga,Bas Weenink,Ya Gao,Marcel Smid,P. Robe,Martin J. van den Bent,Pim J. French	2015	29

About Maarten M.J. Wijnenga

Maarten M.J. Wijnenga is a scholar working on Genetics, Family Practice and Radiology, Nuclear Medicine and Imaging, having authored 21 papers that have together received 818 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (19 papers), Radiomics and Machine Learning in Medical Imaging (10 papers), Meningioma and schwannoma management (4 papers), Brain Metastases and Treatment (3 papers), MicroRNA in disease regulation (3 papers), Medical Imaging Techniques and Applications (2 papers), Neuroblastoma Research and Treatments (2 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Genetics (683 citations), Radiology, Nuclear Medicine and Imaging (436 citations) and Structural Biology (19 citations). Maarten M.J. Wijnenga has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Martin J. van den Bent, Hendrikus J. Dubbink, Marion Smits, Pim J. French, Arnaud J.P.E. Vincent, Johan M. Kros, Peggy N. Atmodimedjo, Renske Gahrmann, Clemens M.F. Dirven and Winand N.M. Dinjens. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact